GETTING MY RAW MATERIALS TO WORK

“The present situation has uncovered some structural weaknesses in the EU’s medicines offer chain along with a large dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She suggested that offer chain troubles be resolved in an EU pharmaceutical tactic predicted to become released by the end in the 12 m